Natco Pharma Ltd.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, NATCO Pharma has informed that the officials of the Company will be meeting investor ‘ICICI Securities’ on 06.03.2024 at 12:00 to 13:00 IST in Hyderabad (In-person (Group). No Unpublished price Sensitive Information (UPSI) is intended to be discussed during the interactions.

The above information is a part of company’s filings submitted to BSE.